Immune-mediated adverse events associated with ipilimumab ctla-4 blockade therapy: the underlying mechanisms and clinical management (Q38166382)
Jump to navigation
Jump to search
scientific article published on 17 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immune-mediated adverse events associated with ipilimumab ctla-4 blockade therapy: the underlying mechanisms and clinical management |
scientific article published on 17 April 2013 |
Statements
1 reference
Immune-mediated adverse events associated with ipilimumab ctla-4 blockade therapy: the underlying mechanisms and clinical management (English)
1 reference
Ahmad Tarhini
1 reference
1 January 2013
1 reference
2 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference